Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Reactions Weekly
Published in: Reactions Weekly 1/2020

01-05-2020 | Osteoarthrosis | Case report

Hydroxychloroquine

Toxic retinopathy: 26 case reports

Published in: Reactions Weekly | Issue 1/2020

Login to get access

Excerpt

In a case-control study, 26 patients (24 women and 2 men) aged 50−88 years were described, who developed toxic retinopathy while receiving hydroxychloroquine for osteoarthritis, psoriatic arthritis, systemic lupus erythematosus (SLE), rheumatoid arthritis, lichen planopilaris, lichen sclerosis or ankylosing spondylitis [routes, times to reactions onsets and outcomes not stated; not all doses stated]. …
Literature
Metadata
Title
Hydroxychloroquine
Toxic retinopathy: 26 case reports
Publication date
01-05-2020
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2020
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-020-79168-3

Other articles of this Issue 1/2020

Reactions Weekly 1/2020 Go to the issue

Case report

Vedolizumab

Case report

Parenteral nutrition supplements

Case report

Adalimumab

Case report

Ruxolitinib

Case report

Multiple drugs

Case report

Multiple drugs